JPRN-UMIN000009973招募中2 期
Phase I Study of Nanoparticle albumin-bound paclitaxel and Cyclophosphamide combination chemotherapy for Patients with Metastatic Breast Cancer(GBCCSG-02) - Phase I Study of AbraC for MBC (GBCCSG-02)
Gunma Breast Clinical Conference Study Group(GBCCSG)0 个研究点目标入组 12 人开始时间: 2013年2月6日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1)History of serious allergy for nab-paclitaxe, cyclophosphamide, paclitaxel or albumin 2)Patients who applied radiation therapy, adjuvant or neo adjuvant chemotherapy within 3 weeks before registraion 3)Serious complication. 4)Active other malignancies 5)Symptomatic brain metastasis 6)peripheral nerve disorder =>Grade2 7)Patients in pregnancy, at risk of pregnancy, 8)Patients judged inappropriate by physicians
研究者
相似试验
已完成
不适用
Phase II study of weekly nanoparticle albumin-bound paclitaxel for patients with metastatic breast cancer (KSCOG-BC04)Breast CancerJPRN-UMIN000008861Department of Surgery, Kurume University School of Medicine55
招募中
不适用
Feasibility study of weekly nanoparticle albumin-bound paclitaxel for patients with metastatic breast cancer (HBCC1101)Breast CancerJPRN-UMIN000007029Hokkaido Cancer Center40
已完成
1 期
PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian CancerPeritoneal CarcinomatosisOvarian Cancer Stage IIIBOvarian Cancer Stage IIICOvarian Cancer Stage IVBreast Cancer Stage IIIBBreast Cancer Stage IIIcBreast Cancer Stage IVStomach Cancer Stage IIIStomach Cancer Stage IV With MetastasesPancreas Cancer, Stage IIIPancreas Cancer, Stage IVNCT03304210University Hospital, Ghent20
Unknown
2 期
Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic CancerAdvanced Pancreatic CancerNCT02124317Chinese PLA General Hospital60
尚未招募
2 期
The Efficacy and Safety of Nanoparticle Albumin-bound (NAB)-Paclitaxel Plus Cisolation Versus CEP (Cisplatin, Epirubicin,Cyclophosphamide) in Induction Therapy for Thymoma: a Study for a Single-center Prospective Phase II Randomized Controlled Train.Histological or Cytological Confirmed Stage Ⅲ and Ⅳa ThymomaNCT05816694Peng Liu50